Daito PharmaceuticalLtd (4577) Stock Overview
Manufactures and sells pharmaceutical products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
4577 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Daito Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,184.00 |
| 52 Week High | JP¥1,311.00 |
| 52 Week Low | JP¥970.00 |
| Beta | 0.045 |
| 1 Month Change | -2.55% |
| 3 Month Change | 14.29% |
| 1 Year Change | 3.91% |
| 3 Year Change | 8.13% |
| 5 Year Change | -36.16% |
| Change since IPO | 91.02% |
Recent News & Updates
Why Daito PharmaceuticalLtd's (TSE:4577) Shaky Earnings Are Just The Beginning Of Its Problems
Jul 20
Recent updates
Why Daito PharmaceuticalLtd's (TSE:4577) Shaky Earnings Are Just The Beginning Of Its Problems
Jul 20Daito PharmaceuticalLtd (TSE:4577) Has Announced A Dividend Of ¥35.00
May 27Daito PharmaceuticalLtd (TSE:4577) Is Due To Pay A Dividend Of ¥35.00
Mar 15Daito PharmaceuticalLtd (TSE:4577) Is Due To Pay A Dividend Of ¥35.00
Feb 04Daito PharmaceuticalLtd's (TSE:4577) Problems Go Beyond Weak Profit
Jan 18Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture
Jul 19Shareholder Returns
| 4577 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -1.7% | 3.2% | 2.1% |
| 1Y | 3.9% | -3.9% | 17.2% |
Return vs Industry: 4577 exceeded the JP Pharmaceuticals industry which returned -3.9% over the past year.
Return vs Market: 4577 underperformed the JP Market which returned 17.2% over the past year.
Price Volatility
| 4577 volatility | |
|---|---|
| 4577 Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 3.7% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in JP Market | 7.7% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4577 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4577's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1942 | 1,073 | Hiroshi Matsumori | www.daitonet.co.jp |
Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. It offers generic drugs, active pharmaceutical ingredients, and over the counter drugs; and contract manufacturing services for formulations products, high-potent drugs, and packaging.
Daito Pharmaceutical Co.,Ltd. Fundamentals Summary
| 4577 fundamental statistics | |
|---|---|
| Market cap | JP¥35.50b |
| Earnings (TTM) | JP¥1.99b |
| Revenue (TTM) | JP¥50.98b |
Is 4577 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4577 income statement (TTM) | |
|---|---|
| Revenue | JP¥50.98b |
| Cost of Revenue | JP¥42.03b |
| Gross Profit | JP¥8.95b |
| Other Expenses | JP¥6.96b |
| Earnings | JP¥1.99b |
Last Reported Earnings
Aug 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 66.23 |
| Gross Margin | 17.55% |
| Net Profit Margin | 3.90% |
| Debt/Equity Ratio | 16.9% |
How did 4577 perform over the long term?
See historical performance and comparisonDividends
Does 4577 pay a reliable dividends?
See 4577 dividend history and benchmarks| Daito PharmaceuticalLtd dividend dates | |
|---|---|
| Ex Dividend Date | Nov 27 2025 |
| Dividend Pay Date | Feb 03 2026 |
| Days until Ex dividend | 45 days |
| Days until Dividend pay date | 113 days |
Does 4577 pay a reliable dividends?
See 4577 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/11 15:26 |
| End of Day Share Price | 2025/10/10 00:00 |
| Earnings | 2025/08/31 |
| Annual Earnings | 2025/05/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Daito Pharmaceutical Co.,Ltd. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yukichi Okabe | Okasan Securities Co. Ltd. |
| Takashi Akahane | Tokai Tokyo Intelligence Laboratory Co., Ltd. |
| Masao Yoshida | Tokai Tokyo Intelligence Laboratory Co., Ltd. |